It has been reported that vaccinations against monkeypox virus have started for individuals in the risk group in the Netherlands. In the statement made by the Dutch Institute of Public Health and Environment (RIVM), it was stated that the first vaccinations against the monkeypox virus started in health centers in Amsterdam and The Hague Municipalities.
In the statement, it was mentioned that 50 people will be vaccinated for monkeypox virus in the center in Amsterdam on the first day and 100 people will be vaccinated every day, and it was noted that the majority of the 32 thousand people invited for the vaccine were male-to-male relationships and transgender individuals. In the statement, it was reported that the vaccine will be administered in two doses, and the second dose will be administered four weeks after the first.
It was emphasized that there are a total of 70,000 monkeypox vaccines in the Netherlands, where the Imvanex vaccine, developed by the Danish Bavarian Nordic company and approved by the European Union Medicines Agency (EMA), is used.
According to the data released by RIVM on July 21, monkeypox virus was detected in 712 people in the Netherlands.
Monkey pox, known as one of the rare diseases caused by an endemic virus, is divided into two as Congo and West African species. The virus, which is usually transmitted from animal to human and rarely from person to person, can cause high fever and itchy blisters on the body.
According to the data of the World Health Organization (WHO), since the beginning of the year, there have been more than 3,000 cases detected in 50 countries or regions in 39 countries.
The World Health Organization (WHO) declared the monkeypox epidemic, which continues to spread in the world, especially in Europe, as an International Public Health Emergency (PHEIC).